Long-Term Survival After Gastrectomy for Cancer in Randomized, Controlled Oncological Trials: Comparison between West and East

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Surgical Oncology

• Publication date

  2013-01-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-012-2862-9PMID 23340695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

  2012cited by this paper
• A meta-analysis of D1 versus D2 lymph node dissection

  2012cited by this paper
• Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2

  2011cited by this paper
• The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.

  2011cited by this paper
• Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

  2011cited by this paper
• Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

  2011cited by this paper
• Multivariate Random-effects Meta-regression: Updates to Mvmeta

  2011cited by this paper
• Hospital volume and survival in oesophagectomy and gastrectomy for cancer.

  2011cited by this paper
• Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

  2010cited by this paper
• A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia.

  2010influential reference
• Implications of overweight in gastric cancer: A multicenter study in a Western patient population.

  2010cited by this paper
• Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram

  2010cited by this paper
• Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical Trial

  2010cited by this paper
• Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

  2010cited by this paper
• Effect of being overweight on postoperative morbidity and long‐term surgical outcomes in proximal gastric carcinoma 1

  2009cited by this paper
• D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

  2008cited by this paper
• Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

  2008cited by this paper
• Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).

  2007cited by this paper
• Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer

  2007cited by this paper
• Nodal dissection for patients with gastric cancer: a randomised controlled trial.

  2006cited by this paper
• Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006influential reference
• Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

  2006cited by this paper
• Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer

  2005cited by this paper
• Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

  2005cited by this paper
• Predictors of operative morbidity and mortality in gastric cancer surgery

  2005cited by this paper
• Gastric cancer in the East: same disease, different patient

  2005cited by this paper
• Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer

  2004cited by this paper
• A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.

  2004cited by this paper
• Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.

  2004cited by this paper
• Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.

  2004cited by this paper
• Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.

  2004cited by this paper
• Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

  2003cited by this paper
• Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group.

  2002cited by this paper
• How should meta‐regression analyses be undertaken and interpreted?

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

  2001cited by this paper
• Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial

  2001cited by this paper
• D2 or not D2? The gastrectomy question

  2001cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial

  2001cited by this paper
• Is gastric carcinoma different between Japan and the United States?

  2000cited by this paper
• Extended lymph-node dissection for gastric cancer.

  1999cited by this paper
• Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

  1999cited by this paper
• Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.

  1999cited by this paper
• Explaining heterogeneity in meta-analysis: a comparison of methods.

  1997cited by this paper
• Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

  1997cited by this paper
• Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer.

  1996cited by this paper
• Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases

  1996cited by this paper
• A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.

  1996cited by this paper
• Comparison of the molecular genetics of c‐erb‐B2 and p53 expression in stomach cancer in Britain and Japan

  1995cited by this paper
• Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

  1995cited by this paper
• Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study

  1995cited by this paper
• Gastric cancer: a curable disease in Britain.

  1993cited by this paper
• Is the prognosis for Japanese and German patients with gastric cancer really different?

  1993cited by this paper
• Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

  1991cited by this paper
• Radical surgery for gastric cancer. A review of the Japanese experience

  1989cited by this paper
• [Radical surgery in gastric cancer].

  1954cited by this paper
• Radical Surgery for Gastric Cancer

  1945cited by this paper

• Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.

  2024cites this paper
• Improved guideline compliance and textbook oncologic outcomes among patients undergoing multimodal treatment and minimally invasive surgery for locally advanced gastric cancer.

  2024cites this paper
• Proximal gastric cancer-time for organ-sparing approach?

  2024cites this paper
• Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review

  2024cites this paper
• A Comprehensive Review of Prognostic Factors in Patients with Gastric Adenocarcinoma

  2023cites this paper
• Neoadjuvant Chemotherapy Improves Oncological Outcomes and Long-Term Survival Among Elderly Patients with Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis

  2023cites this paper
• Lactate Dehydrogenase and Risk of Readmission with Gastric Cancer: A Propensity Score Matching Analysis

  2023cites this paper
• Impact of robotic and open surgery on patient wound complications in gastric cancer surgery: A meta‐analysis

  2023cites this paper
• Minimally Invasive Surgery for Perihilar Cholangiocarcinoma: A Systematic Review of the Short- and Long-Term Results

  2023cites this paper
• Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes

  2022influential citation
• Immunotherapy for Esophageal Cancer: State-of-the Art in 2021

  2022cites this paper
• The correlation between the preoperative number of lymphocytes and monocytes and the postoperative outcomes of gastric cancer patients

  2022cites this paper
• Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country

  2022cites this paper
• Gastrectomy mortality in Australia

  2022cites this paper
• Comparison of the sixth, seventh, and eighth editions of the American Joint Committee on Cancer Tumor-Node-Metastasis staging system for gastric cancer

  2021cites this paper
• Surgical Treatment for Gastric Cancer.

  2021cites this paper
• An Evaluation of the Effect of Preoperative Inflammation-based Factors on Survival in Gastric Cancer Patients.

  2021cites this paper
• Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS)

  2021cites this paper
• Relación del índice nutricional pronóstico con complicaciones y mortalidad en los pacientes con cáncer gástrico sometidos a gastrectomía en un hospital de tercer nivel de Bogotá, Colombia

  2021cites this paper
• Data Set for Reporting Carcinoma of the Stomach in Gastrectomy.

  2021cites this paper
• Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis.

  2021cites this paper
• Laparoscopic versus Open Surgery for Gastric Cancer in Western Countries: A Systematic Review and Meta-Analysis of Short- and Long-Term Outcomes

  2021cites this paper
• Long Non-Coding RNA NRON promotes Tumor Proliferation by regulating ALKBH5 and Nanog in Gastric Cancer

  2021cites this paper
• Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold

  2021cites this paper
• Burgeoning study of sentinel-node analysis on management of early gastric cancer after endoscopic submucosal dissection

  2020cites this paper
• Racial Disparities in Outcomes Among Asians With Gastric Cancer in the USA

  2020cites this paper
• World Journal of Clinical Oncology Role of imaging biomarkers in mutation-driven non-small cell lung

  2020cites this paper
• Carcinoma of the Stomach Histopathology Reporting Guide

  2020cites this paper
• Is there a role for treatment-oriented surgery in liver metastases from gastric cancer?

  2020cites this paper
• Analysis of the expression and genetic alteration of CLDN18 in gastric cancer

  2020cites this paper
• Textbook Outcome and Survival in Patients With Gastric Cancer

  2020cites this paper
• Thirty-day Readmission After Radical Gastrectomy for Gastric Cancer: A Meta-analysis.

  2019cites this paper
• Gastric cancer: factors affecting survival

  2019cites this paper
• Reply to: “Multimodal Treatment of Locally Advanced Gastric Cancer: Will the West Meet the East?”, by Marino, Elisabetta et al.

  2019cites this paper
• Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years?

  2019cites this paper
• Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience

  2019cites this paper
• Long non-coding RNA DNM3OS promotes tumor progression and EMT in gastric cancer by associating with Snail.

  2019cites this paper
• Influence of race and geographic setting on the management of gastric adenocarcinoma

  2019influential citation
• Neoadjuvant Treatment for Gastric Cancer

  2019cites this paper
• Compound Kushen Injection for gastric cancer

  2019cites this paper
• Impact of postoperative complications on long-term outcomes of patients following surgery for gastric cancer: A systematic review and meta-analysis of 64 follow-up studies.

  2019cites this paper
• CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway

  2019cites this paper
• Understanding Survival Disparities in Gastric Cancer

  2019cites this paper
• CMAR_A_222620 10135..10143

  2019cites this paper
• The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis.

  2018cites this paper
• Gastrectomy with Extended Lymphadenectomy: a North American Perspective

  2018cites this paper
• Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis

  2018cites this paper
• Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer

  2018cites this paper
• Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital

  2018cites this paper
• Differences in gastric cancer surgery outcome between East and West : differences in surgery or different diseases ?

  2018cites this paper
• Rekonstruktionsverfahren nach resezierenden Eingriffen am Ösophagus

  2017cites this paper
• Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden

  2017cites this paper
• How Do We Bridge the West and the East in the Treatment for Gastric Cancer?

  2017cites this paper
• Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study

  2017cites this paper
• Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography

  2017cites this paper
• Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project

  2017cites this paper
• Hepatectomy for liver metastases from gastric cancer: a systematic review

  2017influential citation
• Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer

  2017cites this paper
• Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England

  2017cites this paper
• Current Progress in the Adjuvant Treatment of Gastric Cancer.

  2017cites this paper
• Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles

  2016cites this paper
• How Do We Bridge the West and the East in the Treatment for Gastric Cancer?

  2016cites this paper
• Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.

  2016cites this paper
• Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival: Systematic Review and Pooled Analysis

  2016cites this paper
• Long-Term Survival in Patients with Postoperative Intra-Abdominal Infectious Complications After Curative Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis

  2016cites this paper
• Artículo Original: Cáncer gástrico, actualidades y perspec- tivas del futuro

  2016cites this paper
• Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative.

  2016cites this paper
• The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival: A Meta-Analysis of Comparative Studies in the Far East

  2016cites this paper
• An update on gastric cancer.

  2016cites this paper
• Adjuvant Chemotherapy: What’s the Rush?

  2016cites this paper
• miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1.

  2016cites this paper
• Is signet-ring cell carcinoma a specific entity among gastric cancers?

  2016cites this paper
• Pathogenesis of Gastric Cancer

  2015cites this paper
• Management of gastric cancer: East vs West.

  2015cites this paper
• Laparoscopic surgery for gastric cancer: a systematic review

  2015cites this paper
• Surgical management of gastric cancer: the East vs. West perspective.

  2015cites this paper
• Screening and Early Detection of Gastric Cancer: East Versus West.

  2015cites this paper
• Adjuvant and Neoadjuvant Options in Resectable Gastric Cancer: Is There an Optimal Treatment Approach?

  2015cites this paper
• Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative

  2015cites this paper
• A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma

  2015cites this paper
• Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

  2015cites this paper
• Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers

  2015cites this paper
• Evidence-Based Operative Details in Esophageal Cancer Treatment: Surgical Approach, Lymphadenectomy, Anastomosis

  2015cites this paper
• Perioperative treatments for resectable gastric cancer

  2015cites this paper
• Perioperative treatments for resectable gastric

  2015cites this paper
• A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.

  2014cites this paper
• An investigation into perioperative outcome following gastrointestinal resection in England

  2014cites this paper
• Les adénocarcinomes à cellules indépendantes : une entité particulière au sein des cancers gastriques ?

  2014cites this paper
• Gastric cancer.

  2010cites this paper